Viking Global’s Performance, AUM, and Long-Term Stock Picks

Published on July 19, 2023 at 8:52 am by Affan Mir in Hedge Funds, News

In this article, we discuss Viking Global’s performance, AUM, and 10 long-term stock picks. To skip the detailed analysis, performance history, and investment philosophy of Andreas Halvorsen’s Viking Global, go directly to Viking Global’s 5 Long-Term Stock Picks.

Andreas Halvorsen is the co-founder of Viking Global and is currently the CEO of the firm. He is one of the most successful Tiger Cubs. Tiger Cubs are mentees of the late Julian Robertson who formed hedge funds of their own. According to Insider Monkey, Andreas Halvorsen is the 20th most successful hedge fund manager in the world with an accumulated net worth of nearly $6 billion since the inception of Viking Global. Viking Global is one of the best hedge funds to work for.

Education and Career

Andreas Halvorsen was born in 1961. He received his Economics degree from Williams College, Massachusetts in 1986 and one faculty member, Jack McDonald said, “He was one of our brightest students ever.” He later completed his MBA at Stanford University Graduate School of Business in 1990. After finishing his studies, he briefly worked at JP Morgan and later joined Julian Robertson’s Tiger Management Corporation in 1992. In 1999, Halvorsen formed Viking Global along with two other Tiger Cubs, David Ott, and Brian Olson. As of July 13, 2023, Andreas Halvorsen is worth $5.9 billion.

Viking Global Hedge Fund Performance

Halvorsen’s Connecticut-based firm makes short-term and long-term investments that are research-intensive and use “thoughtful risk-taking”. Healthcare stocks take the highest percentage of Viking Global’s portfolio followed by the tech segment and financial stocks take the third spot in the hedge fund’s portfolio. While defining his investment strategy, Andreas Halvorsen said:

“We are stock pickers. We believe that our thoughtful analysis and disciplined valuation over time yield a diversified portfolio of longs and shorts whose stock price developments will deviate from each other and provide a profitable spread.”

Since 2014, Viking Global uses Transaction Cost Analysis (TCA) system created by its software development team. The system measures the cost of trading, helping the firm’s traders to become more efficient.

In 2017, Viking Global returned $8 billion to its investors to “reset to a smaller size,” as the company’s chief investment officer, Daniel Sundheim, decided to leave. Within the next three years, the hedge fund managed to grow its capital back to its pre-return level.

In the last decade, Viking Global has gained nearly 77%. The firm posted a 4.5% loss in 2021 while S&P 500 gained over 27% in the year. It was the firm’s fourth loss since inception and was its worst year on record. Halvorsen said that he “underestimated the ongoing impact of Covid,” and misjudged the normalization of consumer spending in 2021. In 2022, Viking Global posted a loss of 3% which can be attributed to the rough macroeconomic conditions due to the rising interest rates and inflation which also affected several other hedge funds. However, the last 12 months have been quite bright for the firm, during which it has gained 21.12%.

As of the first quarter of 2023, Viking Global manages over $38 billion of capital in public and private investments. According to its Q1 13F filing, the firm had $21.3 billion in managed 13F securities up from nearly $20 billion in the previous quarter. The firm added 20 new stocks to its portfolio including Lululemon Athletica Inc. (NASDAQ:LULU) and The Sherwin-Williams Company (NYSE:SHW), and sold out of 18 stocks including Uber Technologies, Inc. (NYSE:UBER) and Advanced Micro Devices, Inc. (NASDAQ:AMD). Viking Global’s top three stock picks include Visa Inc. (NYSE:V), McKesson Corporation (NYSE:MCK), and UnitedHealth Group Incorporated (NYSE:UNH). You can also check out Viking Global’s top 15 stock picks.

Ole Andreas Halvorsen of Viking Global

Our Methodology

For this article, we chose the 10 longest-held stock positions of Andreas Halvorsen’s Viking Global. The holding history record for each position was taken from Viking Global’s data provided by Insider Monkey. We listed the stocks in ascending order of their value in the hedge fund’s 13F portfolio at the end of Q1 2023.

Viking Global’s Performance, AUM, and Long-Term Stock Picks

10. Boston Scientific Corporation (NYSE:BSX)

Stock Held by Viking Global Since: Q3 2018

Percentage of Viking Global’s Portfolio as of Q1 2023: 0.26%

Boston Scientific Corporation (NYSE:BSX) is an American healthcare company that develops medical devices primarily for minimally invasive medical procedures. The company was quite popular among billionaire hedge funds in the first quarter of 2023 with 17 billionaire investors bullish on Boston Scientific Corporation (NYSE:BSX)’s stock.

Boston Scientific Corporation (NYSE:BSX) has been in Viking Global’s investment portfolio since the third quarter of 2018. In Q1 2023, the firm held over 1.136 million of the company shares worth $56.878 million, covering 0.26% of the hedge fund’s portfolio. In the same quarter, Boston Scientific Corporation (NYSE:BSX) stock was held by 65 hedge funds and Citadel Investment Group was the leading shareholder with 15 million shares worth over $751 million.

Boston Scientific Corporation (NYSE:BSX) is expected to hold its second quarter 2023 conference call on July 27 to discuss its quarterly results which will be posted earlier on the same day.

Visa Inc. (NYSE:V), McKesson Corporation (NYSE:MCK), and UnitedHealth Group Incorporated (NYSE:UNH) are some of the most prominent stocks in Viking Global’s portfolio along with Boston Scientific Corporation (NYSE:BSX).

Here is what Artisan Partners specifically said about Boston Scientific Corporation (NYSE:BSX) in its Q2 2022 investor letter:

“We took advantage of Boston Scientific Corporation (NYSE:BSX)’s share price pullback during the quarter. We believe the company is well-positioned to benefit from an expected return of elective medical procedures and several innovative product profit cycles in the periods ahead. Meanwhile, the company’s health care end market could prove relatively resilient in a recession scenario.”

9. Guardant Health, Inc. (NASDAQ:GH)

Stock Held by Viking Global Since: Q3 2019

Percentage of Viking Global’s Portfolio as of Q1 2023: 0.27%

Guardant Health, Inc. (NASDAQ:GH) is an American diagnostics and research company headquartered in Palo Alto, California. Viking Global has held a position in the company stock since the third quarter of 2019. In the first quarter of 2023, Guardant Health, Inc. (NASDAQ:GH) represented 0.27% of the hedge fund’s portfolio with approximately 2.54 million shares, valued at $59.51 million.

On July 5, Guardant Health, Inc. (NASDAQ:GH) announced that it has received a national reimbursement approval for its Guardant360® CDx liquid biopsy test for comprehensive genomic profiling (CGP) from the Japanese Ministry of Health, Labor and Welfare (MHLW) to diagnose patients with advanced solid tumor cancers.

On July 4, JP Morgan assumed coverage of Guardant Health, Inc. (NASDAQ:GH) with an Overweight rating and a $65 price target.

Aristotle Atlantic Partners, LLC made the following comment about Guardant Health, Inc. (NASDAQ:GH) in its Q4 2022 investor letter:

“Guardant Health, Inc. (NASDAQ:GH) shares were weak following the release of the pivotal Eclipse trial in over 20,000 patients to evaluate performance of its blood-based test, Shield, for detecting colorectal cancer (CRC) in average-risk adults. Sensitivity was 83%, marginally below investor expectations of 85%. Detection of advanced adenomas (AA) came in at 13% which was lower than the 20% update that took the stock down previously. We believe, as does the company, that the results are sufficient to gain FDA approval for the minimally invasive blood screening test and to capture a meaningful share of the 49 million average-risk adults who are recommended for screening and yet are still not screened.”

8. Catalent, Inc. (NYSE:CTLT)

Stock Held by Viking Global Since: Q1 2018

Percentage of Viking Global’s portfolio as of Q1 2023: 0.37%

Catalent, Inc. (NYSE:CTLT) is an American multinational pharmaceutical company headquartered in New Jersey. The company specializes in delivery technologies, biopharmaceuticals, gene therapies, and consumer health.

Viking Global initiated a position in Catalent, Inc. (NYSE:CTLT) in the first quarter of 2018 with over 1.5 million shares. In that quarter, the average share price of Catalent, Inc. (NYSE:CTLT) was $42.54 per share. In the first quarter of 2023, the hedge fund held over 1.2 million shares of the company worth $78.9 million, representing 0.37% of Viking Global’s investment portfolio. The average share price of Catalent, Inc. (NYSE:CTLT) in Q1 2023 was $61.79.

In Q1 2023, Catalent, Inc. (NYSE:CTLT)’s shares were held by 42 hedge funds at a combined value of $1.19 billion, up from 31 hedge funds with a total stake value of $734.588 million in Q4 2022.

Aristotle Capital Boston, LLC made the following comment about Catalent, Inc. (NYSE:CTLT) in its first quarter 2023 investor letter:

“Catalent, Inc. (NYSE:CTLT), a pharmaceutical contract development and manufacturing organization, appreciated amid positive momentum within the company’s Biologics segment, a renewed focus on improving efficiencies, and rumblings that the company may be acquired. We maintain a position, as we believe the long-term value creation opportunity for the company remains intact, driven by favorable outsourcing trends and the company’s competitive position in biologics, particularly within the company’s cell and gene therapy sub-segments.”

7. Molina Healthcare, Inc. (NYSE:MOH)

Stock Held by Viking Global Since: Q3 2019

Percentage of Viking Global’s Portfolio as of Q1 2023: 0.74%

Molina Healthcare, Inc. (NYSE:MOH) offers government-sponsored healthcare like Medicaid and Medicare to the citizens of the US. It is one of the biggest health insurance companies in the US. Viking Global started its position in the company in the third quarter of 2019. Previously, the hedge fund also held Molina Healthcare, Inc. (NYSE:MOH)’s stock in the third quarter of 2015 and later from Q2 to Q4 of 2017.

On June 30, the company announced that it will acquire Bright Health Group, Inc. (NYSE:BHG)’s subsidiary CA Health Plans, comprising Brand New Day and Central Health Plan of California for $510 million.

On July 7, JP Morgan analyst Calvin Sternick lowered the price target on Molina Healthcare, Inc. (NYSE:MOH)’s stock from $348 to $341 while keeping an Overweight rating on its shares. The firm’s price target shows a 16.9% upside to the company’s stock price of $291.7 as of July 12.

Molina Healthcare, Inc. (NYSE:MOH) saw positive hedge fund sentiment in the first quarter of 2023 as it was held by 41 hedge funds in Q1, compared to 38 funds in the previous quarter.

Scout Investments mentioned Molina Healthcare, Inc. (NYSE:MOH) in its third-quarter 2022 investor letter. Here is what it said:

“Molina Healthcare, Inc. (NYSE:MOH) also performed well as sentiment toward health maintenance organizations improved, both as a relatively defensive investment during uncertain times, and as the bear case on the stock was partially debunked with an extension of expanded enrollment for government health insurance programs.”

6. Adaptive Biotechnologies Corporation (NASDAQ:ADPT)

Stock Held by Viking Global Since: Q2 2019

Percentage of Viking Global’s Portfolio as of Q1 2023: 1.24%

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) is a Seattle-based biotech company that designs, manufactures, and sells diagnostic and treatment equipment to its clients in the US.

According to Insider Monkey’s database, Viking Global was the biggest shareholder of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) in Q1 2023 with 29 million shares worth $264.844 million, making up 1.24% of the fund’s portfolio. Meanwhile, Catherine D. Wood’s ARK Investment Management bought nearly 1.25 million shares of the company between May 10 and July 10, 2023. Viking Global initiated its position in Adaptive Biotechnologies Corporation (NASDAQ:ADPT) in the second quarter of 2019.

In the last three months, five Wall Street analysts have covered Adaptive Biotechnologies Corporation (NASDAQ:ADPT) stock. Four analysts keep a Buy or Outperform rating on the company stock. The average analyst price target for the company stands at $14 which shows an 84.9% upside to the company’s stock price of $7.57 as of the market close on July 12.

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) is one of the most significant stock picks of Viking Global, along the likes of Visa Inc. (NYSE:V), McKesson Corporation (NYSE:MCK), and UnitedHealth Group Incorporated (NYSE:UNH).

Click to continue reading and see Viking Global’s 5 Long-Term Stock Picks.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on October 6, 2025 at by Inan Dogan, PhD

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

175 Teslas
107 Amazons
140 Metas
84 Googles
65 Microsofts
And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

Insider Monkey Ads

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on October 5, 2025 at by Inan Dogan, PhD

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

The AI infrastructure supercycle
The onshoring boom driven by Trump-era tariffs
A surge in U.S. LNG exports
And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

Access to our Detailed Report on our AI, Tariffs, and Nuclear Energy Stock with 100+% potential upside within 12 to 24 months
BONUS REPORT on our #1 AI-Robotics Stock with 10000% upside potential: Our in-depth report dives deep into our #1 AI/robotics stock’s groundbreaking technology and massive growth potential.
One New Issue of Our Premium Readership Newsletter: You will also receive one new issue per month and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.
One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149
Bonus Content: Premium access to members-only fund manager video interviews
Ad-Free Browsing: Enjoy a month of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
Lifetime Price Guarantee: Your renewal rate will always remain the same as long as your subscription is active.
30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up

Viking Global’s Performance, AUM, and Long-Term Stock Picks

Published on July 19, 2023 at 8:52 am by Affan Mir in Hedge Funds, News

Education and Career

Viking Global Hedge Fund Performance

Viking Global’s Performance, AUM, and Long-Term Stock Picks

10. Boston Scientific Corporation (NYSE:BSX)

9. Guardant Health, Inc. (NASDAQ:GH)

8. Catalent, Inc. (NYSE:CTLT)

7. Molina Healthcare, Inc. (NYSE:MOH)

6. Adaptive Biotechnologies Corporation (NASDAQ:ADPT)

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on October 6, 2025 at by Inan Dogan, PhD

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on October 5, 2025 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up:

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Premium

Log In

Sign Up

Viking Global’s Performance, AUM, and Long-Term Stock Picks

Published on July 19, 2023 at 8:52 am by Affan Mir in Hedge Funds, News

Share

Education and Career

Viking Global Hedge Fund Performance

Viking Global’s Performance, AUM, and Long-Term Stock Picks

10. Boston Scientific Corporation (NYSE:BSX)

9. Guardant Health, Inc. (NASDAQ:GH)

8. Catalent, Inc. (NYSE:CTLT)

7. Molina Healthcare, Inc. (NYSE:MOH)

6. Adaptive Biotechnologies Corporation (NASDAQ:ADPT)

Share

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on October 6, 2025 at by Inan Dogan, PhD

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on October 5, 2025 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up: